MACQUARIE GROUP LTD

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1418333 Sydney, NSW 2000, C3

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,000

-$1,866,162 QoQ

Shares Held

3,000

-98.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#268

of 316 holders

Holding Since

Jun 2020

12 quarters on record

Healthcare · as of Jun 30, 2026

MACQUARIE GROUP LTD holds $49,746,703 across 12 Drug Manufacturers - Specialty & Generic names. BCRX ranks #9 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	347,374	$24,962,294
2	BHC	Bausch Health Companies Inc.	3,250,000	$16,022,500
3	UTHR	UNITED THERAPEUTICS Corp	5,329	$2,887,412
4	NBIX	Neurocrine Biosciences Inc	13,870	$2,337,649
5	TEVA	Teva Pharmaceutical Industries Ltd	56,337	$1,908,697
6	VTRS	Viatris Inc	58,191	$924,071
7	LNTH	Lantheus Holdings, Inc.	4,951	$549,263
8	HIMS	Hims & Hers Health, Inc.	2,500	$86,675

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,000	3,000	-98.8%	Shares	Sole	2026-08-14
2024-09-30	$1,896,162	249,495	+4871.0%	Shares	Sole	2024-11-14
2022-09-30	$63,239	5,019	-20.6%	Shares	Sole	2022-11-14
2022-06-30	$66,876	6,321	0.0%	Shares	Defined	2022-08-17
2022-03-31	$102,779	6,321	-23.9%	Shares	Defined	2022-05-16
2021-12-31	$115,024	8,305	+27.7%	Shares	Defined	2022-02-11
2021-09-30	$93,433	6,502	-24.4%	Shares	Defined	2021-11-12
2021-06-30	$136,045	8,605	+3.0%	Shares	Defined	2021-08-13
2021-03-31	$84,939	8,352	-15.9%	Shares	Defined	2021-05-14
2020-12-31	$73,993	9,932	0.0%	Shares	Defined	2021-02-16
2020-09-30	$34,166	9,932	+47.5%	Shares	Defined	2020-11-13
2020-06-30	$32,044	6,732	—	Shares	Defined	2020-08-11
No filing history on record for this holder in this stock.